GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sharps Technology Inc (NAS:STSS) » Definitions » 10-Year RORE %

STSS (Sharps Technology) 10-Year RORE % : 0.00% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sharps Technology 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Sharps Technology does not have enough data to calculate 10-Year RORE %.


Sharps Technology 10-Year RORE % Historical Data

The historical data trend for Sharps Technology's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharps Technology 10-Year RORE % Chart

Sharps Technology Annual Data
Trend Dec20 Dec21 Dec22 Dec23
10-Year RORE %
- - - -

Sharps Technology Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sharps Technology's 10-Year RORE %

For the Medical Instruments & Supplies subindustry, Sharps Technology's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sharps Technology's 10-Year RORE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sharps Technology's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Sharps Technology's 10-Year RORE % falls into.


;
;

Sharps Technology 10-Year RORE % Calculation

Sharps Technology's 10-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( - )/( - )
=/
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 10-year before.


Sharps Technology  (NAS:STSS) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Sharps Technology 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Sharps Technology's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sharps Technology Business Description

Traded in Other Exchanges
N/A
Address
105 Maxess Road, Suite 124, Melville, NY, USA, 11747
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.
Executives
Robert Michael Hayes director, officer: Chief Executive Officer 75 BROOKSHIRE DRIVE, YOUNGSVILLE NC 27596
Andrew R. Crescenzo officer: Chief Financial Officer C/O ENZO BIOCHEM, 527 MADISON AVENUE, NEW YORK NY 10022
Timothy James Ruemler director 3311 RIVERPARK CT., BENITA SPRINGS FL 34134
Alan R. Blackman director, officer: CIO and COO 11502 ROBLES DR. REPP PLACE, TEMPLE TERRACE FL 33617
Paul K Danner director
Soren Bo Christiansen director 4059 SPRING VALLEY ROAD, DOYLESTOWN PA 18902
Brenda Baird Simpson director 7336 PRAIRIE STAR COURT,, PARKER CO 80134
Jason L. Monroe director 14527 LINDALE ROSE LANE, HUMBLE TX 77379
Barry Boris Berler officer: CTO and Inventor 77 HERZL STREET, RAMAT GAN L3 5244352

Sharps Technology Headlines

From GuruFocus